Small Molecule Antibody

The company focuses on yeast molecular biology technology as its research and development direction, and relies on independent innovative technology platforms such as "high-throughput yeast interaction technology", "yeast secretion expression", and "yeast display" to provide a full chain and scenario application solution for yeast


Ruiyuan Biotechnology

Nanobody Screening (Nuclear System)

The antigen-binding capacity of nanobodies is similar to conventional antibodies for three reasons. First, the complementarity-determining region 3 (CDR3) of nanobodies is similar or even longer than that of human VH domain (variable domain of heavy immunoglobulin chain).

See More


Do you have a question?

Do you have a question for us?

contact our experts

Explore More →

Any question? Get in touch with us!